Human platelet antigen‐1 (Zw) typing of fetuses by analysis of polymerase chain reaction‐amplified genomic DNA from amniocytes

  • S. Simsek
  • , G. C.L.M. Christiaens
  • , H. H.H. Kanhai
  • , J. R. Beekhuis
  • , P. M.M. Bleeker
  • , A. B.J. Vlekke
  • , R. Goldschmeding
  • , A. E.G. Kr. von dem Borne*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)

Abstract

SUMMARY. Prenatal typing for the human platelet antigens‐1 (HPA) permits identification of a fetus at risk for neonatal alloimmune thrombocytopenia (NAITP) in cases of HPA‐1 incompatibility in which the father is heterozygous for the HPA‐la antigen. Diagnostic cordocentesis and phenotyping of the fetal platelets are used for this purpose. We applied allele‐specific restriction enzyme analysis on polymerase chain reaction (PCR)‐amplified DNA purified from amniocytes. This assay allows early second trimester typing for HPA‐1 alleles. We were able to determine the genotype of three fetuses at risk. Iatrogenic fetal loss is lower with amniocentesis than with cordocentesis. Therefore, this technique is a welcome addition to the antenatal management of NAITP.

Original languageEnglish
Pages (from-to)15-19
Number of pages5
JournalTransfusion Medicine
Volume4
Issue number1
DOIs
Publication statusPublished - Mar 1994

Keywords

  • allele‐specific restriction enzyme analysis
  • DNA polymorphism
  • HPA‐1 (Zw/P1)
  • neonatal alloimmune thrombocytopenia
  • platelets
  • prenatal diagnosis

Fingerprint

Dive into the research topics of 'Human platelet antigen‐1 (Zw) typing of fetuses by analysis of polymerase chain reaction‐amplified genomic DNA from amniocytes'. Together they form a unique fingerprint.

Cite this